Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
Toward the end of trading Friday, the Dow traded up 0.40% to 35,204.21 while the NASDAQ fell 0.41% to 14,833.72. The S&P also rose, gaining 0.16% to 4,435.97.
Midway through trading Friday, the Dow traded up 0.46% to 35,225.33 while the NASDAQ fell 0.70% to 14,791.01. The S&P also rose, gaining 0.07% to 4,432.28.
Following the market opening Friday, the Dow traded up 0.37% to 35,193.61 while the NASDAQ fell 0.26% to 14,857.09. The S&P also rose, gaining 0.16% to 4,436.02.
Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) has received an FDA Complete Response Letter (CRL) regarding its marketing application for Rolontis (eflapegrastim) for neutropenia…